Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1993 Dec;80(4):511–517.

Induction of tolerance by T-cell vaccination is possible beyond the area of autoimmunity: down-regulation of immunity directed to foreign protein antigens.

M J Jacobs 1, A E van den Hoek 1, L B van de Putte 1, W B van den Berg 1
PMCID: PMC1422254  PMID: 8307603

Abstract

T-cell vaccination using antigen-specific lines or clones has been shown to be effective in down-regulating immunity in various experimental autoimmune models. Anti-idiotypic networks developing during differentiation of the immune system are considered to be a safeguard against autoimmunity and these pre-existing networks are supposed to be a prerequisite for successful vaccination. However, the interesting question of feasibility of T-cell vaccination beyond the area of autoimmunity remains to be answered. The present study is the first one providing evidence of successful T-cell vaccination in mice immunized against foreign protein antigens (in this system supposedly no pre-existing network exists). Intraperitoneal (i.p.) administration of hen egg lysozyme (HEL)- and chicken egg albumin (OVA)-specific lymph node cells (LNC) were shown to effectively down-regulate immunity (as measured in a delayed type of hypersensitivity) to HEL and OVA, respectively. In contrast, vaccination was unsuccessful with methylated bovine serum albumin (mBSA)-specific LNC in mBSA immunity. Suppression induced by HEL- and OVA-specific LNC was antigen specific. Unlike the greater part of other studies, in which antigen-specific lines or clones were used, we used draining LNC of immunized mice, which after activation were fixed with glutardialdehyde and injected i.p. 10 days before immunization. Finally, effects of T-cell vaccination were studied in a chronic HEL-induced arthritis. Joint swelling, cell influx and cartilage matrix depletion were significantly less in mice treated with antigen-specific cells. We conclude that successful vaccination is feasible in mice rendered immune to foreign protein antigens using a pool of LNC as source of vaccine, suggesting no necessity of a strong pre-existing network.

Full text

PDF
511

Images in this article

514Figure 5
on p.514

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beraud E., Lider O., Baharav E., Reshef T., Cohen I. R. Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector cells (1). Characteristics of vaccination. J Autoimmun. 1989 Feb;2(1):75–86. doi: 10.1016/0896-8411(89)90109-1. [DOI] [PubMed] [Google Scholar]
  2. Bersani-Amado C. A., Barbuto J. A., Jancar S. Comparative study of adjuvant induced arthritis in susceptible and resistant strains of rats. II. Effect of oral administration of BCG and PPD. J Rheumatol. 1990 Jun;17(6):738–742. [PubMed] [Google Scholar]
  3. Brahn E., Trentham D. E. Attenuation of collagen arthritis and modulation of delayed-type hypersensitivity by type II collagen reactive T-cell lines. Cell Immunol. 1987 Oct 1;109(1):139–147. doi: 10.1016/0008-8749(87)90299-1. [DOI] [PubMed] [Google Scholar]
  4. Chiocchia G., Boissier M. C., Ronziere M. C., Herbage D., Fournier C. T cell regulation of collagen-induced arthritis in mice. I. Isolation of Type II collagen-reactive T cell hybridomas with specific cytotoxic function. J Immunol. 1990 Jul 15;145(2):519–525. [PubMed] [Google Scholar]
  5. Cohen I. R., Atlan H. Network regulation of autoimmunity: an automation model. J Autoimmun. 1989 Oct;2(5):613–625. doi: 10.1016/s0896-8411(89)80001-0. [DOI] [PubMed] [Google Scholar]
  6. Cohen I. R., Holoshitz J., van Eden W., Frenkel A. T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis. Arthritis Rheum. 1985 Aug;28(8):841–845. doi: 10.1002/art.1780280802. [DOI] [PubMed] [Google Scholar]
  7. Cohen I. R. T-cell vaccination against autoimmune disease. Hosp Pract (Off Ed) 1989 Feb 15;24(2):57–64. doi: 10.1080/21548331.1989.11703657. [DOI] [PubMed] [Google Scholar]
  8. Cohen I. R., Weiner H. L. T-cell vaccination. Immunol Today. 1988 Nov;9(11):332–335. doi: 10.1016/0167-5699(88)91330-8. [DOI] [PubMed] [Google Scholar]
  9. Danon D., Goldstein L., Marikovsky Y., Skutelsky E. Use of cationized ferritin as a label of negative charges on cell surfaces. J Ultrastruct Res. 1972 Mar;38(5):500–510. doi: 10.1016/0022-5320(72)90087-1. [DOI] [PubMed] [Google Scholar]
  10. Dorf M. E., Kuchroo V. K., Collins M. Suppressor T cells: some answers but more questions. Immunol Today. 1992 Jul;13(7):241–243. doi: 10.1016/0167-5699(92)90002-O. [DOI] [PubMed] [Google Scholar]
  11. Dua H. S., Gregerson D. S., Donoso L. A. Inhibition of experimental autoimmune uveitis by retinal photoreceptor antigens coupled to spleen cells. Cell Immunol. 1992 Feb;139(2):292–305. doi: 10.1016/0008-8749(92)90072-w. [DOI] [PubMed] [Google Scholar]
  12. Hämmerling G. J. T lymphocyte tissue culture lines produced by cell hybridization. Eur J Immunol. 1977 Oct;7(10):743–746. doi: 10.1002/eji.1830071018. [DOI] [PubMed] [Google Scholar]
  13. Kakimoto K., Katsuki M., Hirofuji T., Iwata H., Koga T. Isolation of T cell line capable of protecting mice against collagen-induced arthritis. J Immunol. 1988 Jan 1;140(1):78–83. [PubMed] [Google Scholar]
  14. Kennedy M. K., Tan L. J., Dal Canto M. C., Miller S. D. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. J Immunol. 1990 Jul 1;145(1):117–126. [PubMed] [Google Scholar]
  15. Klasen I. S., Ladestein R. M., Donselaar I. G., van den Berg W. B., Tees R., Benner R. Joint inflammation in mice induced by a MT4+ Lyt-2- T cell clone. Characteristics and the induction of flare-up reactions. J Immunol. 1987 Nov 15;139(10):3275–3280. [PubMed] [Google Scholar]
  16. Kruijsen M. W., van den Berg W. B., van de Putte L. B., van den Broek W. J. Detection and quantification of experimental joint inflammation in mice by measurement of 99mTc-pertechnetate uptake. Agents Actions. 1981 Dec;11(6-7):640–642. doi: 10.1007/BF01978775. [DOI] [PubMed] [Google Scholar]
  17. Lider O., Beraud E., Reshef T., Friedman A., Cohen I. R. Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector T cells. (2). Induction of a protective anti-idiotypic response. J Autoimmun. 1989 Feb;2(1):87–99. doi: 10.1016/0896-8411(89)90110-8. [DOI] [PubMed] [Google Scholar]
  18. Lider O., Karin N., Shinitzky M., Cohen I. R. Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4577–4580. doi: 10.1073/pnas.84.13.4577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lider O., Reshef T., Beraud E., Ben-Nun A., Cohen I. R. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science. 1988 Jan 8;239(4836):181–183. doi: 10.1126/science.2447648. [DOI] [PubMed] [Google Scholar]
  20. Lider O., Santos L. M., Lee C. S., Higgins P. J., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol. 1989 Feb 1;142(3):748–752. [PubMed] [Google Scholar]
  21. Lohse A. W., Mor F., Karin N., Cohen I. R. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science. 1989 May 19;244(4906):820–822. doi: 10.1126/science.2471264. [DOI] [PubMed] [Google Scholar]
  22. Maron R., Zerubavel R., Friedman A., Cohen I. R. T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice. J Immunol. 1983 Nov;131(5):2316–2322. [PubMed] [Google Scholar]
  23. Mekori Y. A., Karin N., Gottesman G., Cohen I. R. Tolerance to experimental contact sensitivity induced by T cell vaccination. Eur J Immunol. 1990 Sep;20(9):2083–2087. doi: 10.1002/eji.1830200929. [DOI] [PubMed] [Google Scholar]
  24. Miller A., Lider O., Roberts A. B., Sporn M. B., Weiner H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):421–425. doi: 10.1073/pnas.89.1.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mukasa A., Itoh M., Tokunaga Y., Hiramine C., Hojo K. Inhibition of a novel model of murine experimental autoimmune orchitis by intravenous administration with a soluble testicular antigen: participation of CD8+ regulatory T cells. Clin Immunol Immunopathol. 1992 Feb;62(2):210–219. doi: 10.1016/0090-1229(92)90074-x. [DOI] [PubMed] [Google Scholar]
  26. Nabozny G. H., Simon L. L., Kong Y. C. Suppression in experimental autoimmune thyroiditis: the role of unique and shared determinants on mouse thyroglobulin in self-tolerance. Cell Immunol. 1990 Nov;131(1):140–149. doi: 10.1016/0008-8749(90)90241-i. [DOI] [PubMed] [Google Scholar]
  27. Naparstek Y., Ben-Nun A., Holoshitz J., Reshef T., Frenkel A., Rosenberg M., Cohen I. R. T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur J Immunol. 1983 May;13(5):418–423. doi: 10.1002/eji.1830130513. [DOI] [PubMed] [Google Scholar]
  28. Offner H., Jones R., Celnik B., Vandenbark A. A. Lymphocyte vaccination against experimental autoimmune encephalomyelitis: evaluation of vaccination protocols. J Neuroimmunol. 1989 Jan;21(1):13–22. doi: 10.1016/0165-5728(89)90154-9. [DOI] [PubMed] [Google Scholar]
  29. Shen W. C., Yang D., Ryser H. J. Colorimetric determination of microgram quantities of polylysine by trypan blue precipitation. Anal Biochem. 1984 Nov 1;142(2):521–524. doi: 10.1016/0003-2697(84)90500-1. [DOI] [PubMed] [Google Scholar]
  30. Singh V. K., Kalra H. K., Yamaki K., Shinohara T. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide. Cell Immunol. 1992 Jan;139(1):81–90. doi: 10.1016/0008-8749(92)90101-t. [DOI] [PubMed] [Google Scholar]
  31. Zhang Z. Y., Lee C. S., Lider O., Weiner H. L. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J Immunol. 1990 Oct 15;145(8):2489–2493. [PubMed] [Google Scholar]
  32. van de Putte L. B., Lens J. W., van den Berg W. B., Kruijsen M. W. Exacerbation of antigen-induced arthritis after challenge with intravenous antigen. Immunology. 1983 May;49(1):161–167. [PMC free article] [PubMed] [Google Scholar]
  33. van den Berg W. B., Kruijsen M. W., van de Putte L. B., van Beusekom H. J., van der Sluis-van der Pol M., Zwarts W. A. Antigen-induced and zymosan-induced arthritis in mice: studies on in vivo cartilage proteoglycan synthesis and chondrocyte death. Br J Exp Pathol. 1981 Jun;62(3):308–316. [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES